Literature DB >> 10699778

The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea.

K D Fine1, R H Seidel, K Do.   

Abstract

BACKGROUND: The prevalence of chronic diarrhea from a colonic disease and the optimal method of its diagnosis have not been ascertained.
METHODS: Eight hundred nine patients with chronic non-bloody diarrhea unassociated with human immunodeficiency virus (HIV) infection underwent colonoscopy with biopsy specimen taken from throughout the colon and, if reached, the terminal ileum. The prevalence and anatomic distribution of ileocolonic histopathology and whether flexible sigmoidoscopy or colonoscopy represents the safest and most cost-effective test for diagnosis were determined.
RESULTS: 122 of 809 patients (15%) had colonic histopathology (microscopic colitis in 80 patients, Crohn's disease in 23, melanosis coli in 8, ulcerative colitis in 5, other forms of colitis in 5, and nodular lymphoid hyperplasia in 1). A correct assessment of colonic histology (normal or abnormal) could have been made from biopsies of the distal colon in 99.7% of patients.
CONCLUSION: In a referral setting, colonic histopathology occurs in 15% of patients with chronic diarrhea without HIV infection. According to this prevalence and the nearly universal diffuse anatomic distribution of colonic disease in these patients, a diagnostic investigation for chronic colonic diarrhea using a 60 cm flexible sigmoidoscope is highly efficient and cost-effective.

Entities:  

Mesh:

Year:  2000        PMID: 10699778     DOI: 10.1016/s0016-5107(00)70362-2

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  27 in total

1.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 2.  Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis.

Authors:  C X W Tan; H S Brand; N K H de Boer; T Forouzanfar
Journal:  Br Dent J       Date:  2017-01-13       Impact factor: 1.626

Review 3.  Evaluation of lower functional gut disorders.

Authors:  Christopher N Andrews; Martin Storr
Journal:  Can J Gastroenterol       Date:  2008-07       Impact factor: 3.522

4.  Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients.

Authors:  Maribel Rodríguez-Torres; Jose F Rodríguez-Orengo; Carlos F Ríos-Bedoya; Alberto Fernández-Carbia; Rosa Salgado-Mercado; Acisclo M Marxuach-Cuétara
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 5.  Microscopic colitis: a review for the surgical endoscopist.

Authors:  Indraneel Datta; Savtaj S Brar; Christopher N Andrews; Marc Dupre; Chad G Ball; W Donald Buie; Paul L Beck
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

Review 6.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

Review 7.  [Histopathology of microscopic colitis].

Authors:  D E Aust
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

8.  Abdominal pain, diarrhea, constipation--which symptom is more indispensable to have a colonoscopy?

Authors:  Jia Cai; Zhe Yuan; Shujun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

9.  The endoscopically normal colon: when is mapping biopsy histopathologically justifiable?

Authors:  V J Elliot; A C Bateman; B Green
Journal:  Frontline Gastroenterol       Date:  2011-12-01

10.  Idiopathic microscopic colitis of rhesus macaques: quantitative assessment of colonic mucosa.

Authors:  Amir Ardeshir; Karen L Oslund; Frank Ventimiglia; Joann Yee; Nicholas W Lerche; Dallas M Hyde
Journal:  Anat Rec (Hoboken)       Date:  2013-06-18       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.